PROMOSCIENCE SRL

Their core work

Promoscience is a Trieste-based SME that provides specialized scientific and technical services across nanoscience research infrastructure, advanced biomaterials manufacturing, and environmental analytics. They contribute to large European research facilities (NFFA-Europe) while also applying their expertise to practical challenges like microplastics toxicity assessment, 3D-printed biomaterials for tissue repair, and sustainable mobility planning. Their work spans from operating and supporting multi-technique nanoscience user access platforms to developing photosensitive biomaterials and electrospinning-based scaffolds for medical applications.

What they specialise in

How they've shifted over time

Promoscience's early H2020 work (2015-2019) centered on foundational research infrastructure and energy planning — supporting the NFFA-Europe nanoscience platform, contributing to diabetes-related biomaterials research (ELASTISLET), and local energy/mobility planning in northeast Italy. From 2021 onward, their focus shifted decisively toward applied biomedical manufacturing (3D-printed scaffolds, photosensitive biomaterials) and environmental health analytics (microplastics toxicity), while maintaining continuity in nanoscience infrastructure through the NEP successor project. The trajectory shows a company moving from general research support toward more specialized, application-oriented contributions in biomaterials and environmental science.

Promoscience is converging on biomedical manufacturing and environmental analytics, making them a strong partner for projects that need advanced materials characterization or health-impact assessment capabilities.

How they like to work

Promoscience operates exclusively as a participant, never coordinating — they are a specialist contributor that joins consortia rather than leading them. With 75 unique partners across 19 countries from just 7 projects, they consistently work in large, multinational consortia (averaging ~11 partners per project). This breadth of connections suggests they are well-networked and adaptable, comfortable integrating into diverse teams rather than anchoring around a fixed set of repeat collaborators.

Promoscience has built an extensive network of 75 unique partners across 19 countries through 7 projects — a remarkably wide reach for a small company. Their base in Trieste, a historic crossroads between Western and Central Europe, positions them well for pan-European collaborations with no strong geographic bias.

What sets them apart

Promoscience occupies an unusual niche: a small private company that bridges nanoscience research infrastructure with applied biomaterials and environmental health — domains that rarely overlap in a single SME. Their long-running involvement in the NFFA-Europe platform (and its successor NEP) gives them deep familiarity with multi-technique characterization facilities, while their parallel work in 3D-printed scaffolds and microplastics analysis shows they can translate infrastructure access into real applications. For consortium builders, they offer a rare combination of research infrastructure know-how and hands-on manufacturing and analytical capability, all within a flexible SME structure.

Highlights from their portfolio

• NEP
  Their largest funded project (EUR 310,675) and a continuation of NFFA-Europe, running until 2027 — signals long-term commitment to European nanoscience infrastructure.
• Imptox
  Addresses the high-profile issue of micro/nanoplastics health impacts using advanced analytical techniques like isotope ratio mass spectrometry — their most topically relevant project for current environmental policy.
• InterLynk
  Represents their most applied biomedical work, combining human platelet lysates with 3D printing and electrospinning for multi-tissue repair scaffolds.